Today: 20 May 2026
JPMorgan stock heads into Tuesday with Trump lawsuit threat and credit-card cap in focus
18 January 2026
2 mins read

JPMorgan stock heads into Tuesday with Trump lawsuit threat and credit-card cap in focus

New York, January 18, 2026, 10:08 EST — Market closed.

  • JPMorgan shares ended the session roughly 1% higher, closing at $312.47.
  • Trump said he intends to sue JPMorgan within two weeks over alleged “debanking.” CEO Jamie Dimon responded, “There was no job offer” for the Fed chair position.
  • Banks want clear guidance on Trump’s plan to cap credit card interest rates at 10% for one year, beginning January 20.

JPMorgan Chase & Co. shares closed up roughly 1% at $312.47. The bank faces renewed political drama ahead of next week after President Donald Trump announced plans to sue over alleged “debanking” within two weeks. CEO Jamie Dimon pushed back, saying, “There was no job offer,” while the bank stated accounts shouldn’t be closed based on political or religious beliefs. Reuters

U.S. stock markets will remain closed Monday in observance of Martin Luther King Jr. Day, delaying trading until Tuesday. Investors get an additional day to digest weekend news before the market reopens.

Bank stocks remain caught up in policy uncertainty, not market moves. Trump plans to cap credit card interest rates at 10% for a year starting January 20, but the White House hasn’t detailed enforcement yet, and experts say Congress would likely have to approve it. Stephen Biggar of Argus Research commented, “I think there will be an ongoing conversation between the industry and the administration.” Brian Mulberry at Zacks Investment Management warned that “policy volatility” will probably keep shares on edge. Moshe Orenbuch from TD Cowen noted a 10% rate cap would lead to “less robust” card features. Reuters

JPMorgan capped the week by spotlighting growth in a fresh area. It announced a new private capital advisory & solutions team, designed to assist companies and sponsors in raising funds outside public stock exchanges. Keith Canton will lead the effort, which merges private-capital advisory with M&A services. “Private markets are a strategic priority for J.P. Morgan,” said Anu Aiyengar, head of global advisory and M&A. Reuters

On Friday, JPMorgan’s major rivals showed mixed results. Bank of America ended up roughly 0.7%, Citigroup rose near 0.5%, while Wells Fargo dropped around 0.7%.

Heading into the long weekend, trading was uneven. U.S. stocks closed Friday close to unchanged. The S&P 500 financial sector ticked higher that day but still posted its steepest weekly drop since October, weighed down by concerns over the proposed cap on credit-card rates.

The week ahead won’t offer an easy trade. Should the cap plan pick up steam, or if banks end up rolling out low-rate cards with fewer perks, it could tighten a key revenue stream that cushions slower loan growth. Traders would then begin recalculating the impact on earnings power.

Headline risk lurks outside the scope of models. Even without a court case, a lawsuit threat from the White House targeting the largest U.S. bank can weigh on the stock. It drags Washington back into focus just when investors crave stability and fewer shocks.

Tuesday’s reopening is the immediate hurdle, with investors focused on fresh updates from the administration about the credit-card initiative and how the sector reacts. The next big macro event comes with the Federal Reserve’s policy meeting on January 27-28, followed by a press conference on January 28.

Stock Market Today

  • Optimi Health Prices $15 Million Oversubscribed Public Offering, Lists on Nasdaq
    May 20, 2026, 11:50 AM EDT. Optimi Health Corp priced an oversubscribed $15 million public offering, issuing 2.4 million shares at $6.25 each, with an option for 360,000 additional shares. The pharmaceutical company, specializing in psychedelic drug products, uplisted its common shares to the Nasdaq Capital Market under the ticker symbol "OPTH". The offering is slated to close around May 21, 2026. Proceeds will fund production scaling, U.S. market expansion, sales growth, and working capital. Joseph Gunnar & Co. acts as the sole underwriter. The company filed effective registration with the SEC, with shares offered only in the U.S. through a prospectus. This move marks a strategic step for Optimi amid growing interest in commercial psychedelic therapies.

Latest articles

Plug Power Stock Gets a UK Hydrogen Jolt — But the Cash Test Isn’t Over

Plug Power Stock Gets a UK Hydrogen Jolt — But the Cash Test Isn’t Over

20 May 2026
Plug Power shares rose 1.2% to $3.35 Wednesday after the company’s 30-megawatt Barrow Green Hydrogen project in the UK reached final investment decision. The stock rebounded after four straight declines, including a 4.1% drop Tuesday. Plug will supply six electrolyzers to the project, which aims to cut natural gas use at a Kimberly-Clark plant by up to 50%. Trading volume reached about 17.9 million shares.
Nu Holdings shares rise as Nubank faces key credit test

Nu Holdings shares rise as Nubank faces key credit test

20 May 2026
Nu Holdings shares rose 2.3% to $12.58 in New York on Wednesday, recouping losses after last week’s earnings. Nubank reported first-quarter revenue above $5 billion and net income of $871 million, but credit loss allowances jumped 33% to $1.79 billion. Early-stage non-performing loans reached 5.0%. The company’s customer base topped 135 million by March.
Intuitive Machines stock jumped 11% Friday — here’s what matters before the next trade
Previous Story

Intuitive Machines stock jumped 11% Friday — here’s what matters before the next trade

Tencent stock price: 0700.HK closes at HK$617.50 as AI push and March results date come into focus
Next Story

Tencent stock price: 0700.HK closes at HK$617.50 as AI push and March results date come into focus

Go toTop